创伤暴露后循环风险生物标志物的文献综述与方法学考量
本文综述了创伤暴露后用于识别不良创伤后神经精神后遗症(APNS)高风险个体及指导个体化干预决策的候选血液生物标志物,包括激素、蛋白质、免疫分子、神经肽、神经递质、mRNA及非编码RNA表达特征,并讨论了其发现与转化的关键考量与挑战,同时介绍了AURORA研究。
要点
- 创伤暴露后部分个体出现APNS,目前难以在创伤后早期识别高风险者及选择最优治疗。
- 候选血液生物标志物包括激素、蛋白质、免疫分子、神经肽、神经递质及RNA表达特征。
- 综述总结了APNS循环风险标志物的文献现状,并讨论发现与转化的关键考量。
核心结论
- 综述总结了创伤暴露后APNS的候选循环风险生物标志物,并讨论了其发现与转化的关键考量与挑战。
研究设计与样本
- 本文为综合性文献综述,未系统报告检索范围与样本量。
- 文中描述了AURORA研究,称其为迄今聚焦创伤暴露后风险与预后因素的最大研究。
主要发现
- 创伤暴露常见,部分个体康复,但相当一部分出现APNS如创伤后应激、重性抑郁及区域性/广泛性慢性肌肉骨骼疼痛。
- APNS造成功能损害、躯体残疾、自杀风险、工作日损失及医疗费用增加等个体与社会负担。
- 当前治疗受限于创伤后早期无法识别APNS高风险个体及无法为个体患者确定最优治疗。
- 综述涵盖的循环生物标志物包括激素、蛋白质、免疫分子、神经肽、神经递质、mRNA及非编码RNA表达特征。
- 遗传与表观遗传生物标志物因近期已有其他综述而未纳入本综述。
临床怎么用
- 综述提示循环风险生物标志物有望辅助识别APNS高风险个体并指导个体化干预决策。
- 综述同时指出这些标志物在发现与转化方面仍存在关键考量与挑战。
局限性
- 本文为文献综述,未系统报告检索策略、纳入标准及样本量等。
- 遗传与表观遗传生物标志物未纳入本综述范围。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Exposure to traumatic events is common. While many individuals recover following trauma exposure, a substantial subset develop adverse posttraumatic neuropsychiatric sequelae (APNS) such as posttraumatic stress, major depression, and regional or widespread chronic musculoskeletal pain. APNS cause substantial burden to the individual and to society, causing functional impairment and physical disability, risk for suicide, lost workdays, and increased health care costs. Contemporary treatment is limited by an inability to identify individuals at high risk of APNS in the immediate aftermath of trauma, and an inability to identify optimal treatments for individual patients. Our purpose is to provide a comprehensive review describing candidate blood-based biomarkers that may help to identify those at high risk of APNS and/or guide individual intervention decision-making. Such blood-based biomarkers include circulating biological factors such as hormones, proteins, immune molecules, neuropeptides, neurotransmitters, mRNA, and noncoding RNA expression signatures, while we do not review genetic and epigenetic biomarkers due to other recent reviews of this topic. The current state of the literature on circulating risk biomarkers of APNS is summarized, and key considerations and challenges for their discovery and translation are discussed. We also describe the AURORA study, a specific example of current scientific efforts to identify such circulating risk biomarkers and the largest study to date focused on identifying risk and prognostic factors in the aftermath of trauma exposure.
引用
- Linnstaedt SD, Zannas AS, McLean SA, et al. Literature review and methodological considerations for understanding circulating risk biomarkers following trauma exposure. Mol Psychiatry. 2019. PMID: 31863020. doi:10.1038/s41380-019-0636-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。